Biogen Inc (BIIB)
Number of days of payables
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 13.74 | 12.35 | 11.13 | 10.00 | 10.29 | 15.48 | 13.91 | 15.10 | 9.62 | 8.94 | 8.29 | 5.63 | 3.97 | 4.42 | 4.54 | 4.65 | 3.68 | 5.22 | 5.38 | 5.22 | |
Number of days of payables | days | 26.56 | 29.57 | 32.79 | 36.52 | 35.46 | 23.58 | 26.23 | 24.18 | 37.96 | 40.81 | 44.05 | 64.81 | 91.98 | 82.55 | 80.42 | 78.54 | 99.08 | 69.86 | 67.88 | 69.95 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 13.74
= 26.56
Biogen Inc's number of days of payables has shown some fluctuations over the past eight quarters. In Q4 2023, the company improved its efficiency in paying its payables, with only 58.11 days required to settle its obligations to suppliers. This represents a significant decrease from the previous quarter, Q3 2023, where it took 64.62 days to pay off payables.
However, looking at a longer trend, Biogen's number of days of payables has generally been increasing since Q1 2022 when it was at 61.00 days. The trend peaked in Q1 2023 at 81.97 days, indicating a slowdown in the company's payments to suppliers.
Overall, Biogen's management of payables shows some variability, but there may be opportunities for the company to optimize its payment processes to maintain a balance between meeting financial obligations and improving cash flow efficiency.
Peer comparison
Dec 31, 2023